MENU
+Compare
RMD
Stock ticker: NYSE
AS OF
Oct 6, 04:59 PM (EDT)
Price
$281.52
Change
+$2.93 (+1.05%)
Capitalization
40.66B

RMD ResMed Forecast, Technical & Fundamental Analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RMD with price predictions
Oct 03, 2025

RMD in +2.86% Uptrend, rising for three consecutive days on October 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RMD advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2025. You may want to consider a long position or call options on RMD as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RMD just turned positive on October 02, 2025. Looking at past instances where RMD's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

RMD moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for RMD crossed bearishly below the 50-day moving average on September 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RMD broke above its upper Bollinger Band on October 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RMD entered a downward trend on October 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. RMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.812) is normal, around the industry mean (10.969). P/E Ratio (29.089) is within average values for comparable stocks, (54.450). Projected Growth (PEG Ratio) (1.877) is also within normal values, averaging (1.741). Dividend Yield (0.008) settles around the average of (0.016) among similar stocks. P/S Ratio (7.974) is also within normal values, averaging (14.774).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RMD is expected to report earnings to fall 1.18% to $2.52 per share on October 23

ResMed RMD Stock Earnings Reports
Q3'25
Est.
$2.52
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.11
Q3'24
Beat
by $0.15
The last earnings report on July 31 showed earnings per share of $2.55, beating the estimate of $2.48. With 205.84K shares outstanding, the current market capitalization sits at 40.66B.
A.I.Advisor
published Dividends

RMD paid dividends on September 18, 2025

ResMed RMD Stock Dividends
А dividend of $0.60 per share was paid with a record date of September 18, 2025, and an ex-dividend date of August 14, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of devices for evaluation and treatment of sleep disorders

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DNL41.320.29
+0.71%
WisdomTree Global ex-US Qual Div Gr ETF
ITDH37.430.14
+0.38%
iShares LifePath Target Date 2060 ETF
HIDV79.290.23
+0.28%
AB US High Dividend ETF
FSEC44.430.05
+0.11%
Fidelity Investment Grade Sec ETF
LIAY255.08N/A
N/A
LifeX 2064 Inflation-Protected Longevity Income ETF

RMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+0.70%
SOLV - RMD
50%
Loosely correlated
-0.80%
BLCO - RMD
42%
Loosely correlated
+2.98%
RVTY - RMD
40%
Loosely correlated
+2.83%
SYK - RMD
39%
Loosely correlated
+1.12%
IDXX - RMD
39%
Loosely correlated
-0.42%
More

Groups containing RMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+0.70%
Pharmaceuticals
category (386 stocks)
40%
Loosely correlated
+0.12%
Pharmaceuticals: Other
category (103 stocks)
37%
Loosely correlated
+0.41%